Process for the preparation of pazopanib or salts thereof
The present invention provides a process for the preparation of pazopanib of Formula Ia or salts, and intermediates thereof.
1. A process for the preparation of pazopanib of Formula Ia or salts thereof
comprising:
i) treating 2,3-dimethyl-6-nitro-2H-indazole with Raney nickel to obtain a compound of Formula II;
ii) treating the compound of Formula II at a temperature of 25° C. to 30° C. with 2,4-dichloropyrimidine to obtain a compound of Formula III
wherein steps i) and ii) are carried out in a single solvent comprising methanol circumventing heating and cooling procedures, and without isolating the compound of Formula II from the reaction mixture;
iii) converting the compound of Formula III to pazopanib of Formula Ia or salts thereof; and
iv) isolating pazopanib of Formula Ia or salts thereof.
2. The process according to claim 1 , wherein the treatment of the compound of Formula II with 2,4-dichloropyrimidine is carried out in the presence of a base.
3. The process according to claim 2 , wherein the base is selected from the group consisting of an organic base and an inorganic base.
4. The process according to claim 3 , wherein the organic base is selected from the group consisting of N,N-diisopropylethylamine, triethylamine, tri-isopropylamine, N,N-2-trimethyl-2-propanamine, N-methylmorpholine, 4-dimethylaminopyridine, 2,6-di-tert-butyl-4-dimethylaminopyridine, 1,4-diazabicyclo[2.2.2]octane, and 1,8-diazabicyclo[5.4.0]undec-7-ene, or mixtures thereof.
5. The process according to claim 3 , wherein the inorganic base is selected from the group consisting of sodium carbonate, and potassium carbonate, sodium hydride, sodium bicarbonate, and potassium bicarbonate, or mixtures thereof.
6. The process according to claim 5 , wherein the base is sodium bicarbonate.